Tolremo raises €9.0M Series A round
24 September 2018· Basel, Switzerland· health, biotech, drug_discovery, oncology, small_molecule_therapeutics, epigenetics, b2b
Expected to cover the period and prepare the grounds for the future growth of the company.
Investors
LeadBioMedPartners
Also participating
redalpineWille FinanceAltos Ventures Management
About Tolremo
Stage
Series A
Headquarters
Basel, Switzerland
Founded
2017
Team Size
6–20
Sectors
healthbiotechdrug_discoveryoncologysmall_molecule_therapeuticsepigeneticsb2b